跳至主要内容
临床试验/DRKS00008765
DRKS00008765已完成未知

Dopaminergic and cholinergic modulation of oculomotor control during saccades

Translational Neuromodeling Unit, Institut für Biomedizinische Technik, Universität Zürich und ETH Zürich0 个研究点目标入组 150 人开始时间: 2015年6月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 40 Years(—)
性别
Male

入选标准

  • Age: =18 and =40 years
  • European ancestry
  • Written informed consent
  • Consent to adhere to the study protocol
  • Ability to adhere to the study protocol

排除标准

  • Serious past or present brain disease, brain injury or brain surgery
  • Any neurological or psychiatric disorders (past or present)
  • Current psychoactive medication
  • Daily nicotin use
  • Daily alcohol use > 2 units per day on average (1 unit = 3 dl beer = 1 dl wine)
  • Current use of recreational drugs
  • History of drug abuse
  • Any current severe medical condition
  • Additional exclusion criteria for the pharmacological study branches:
  • Tachy- or bradycardia (normal range 55-100 bpm), cardiac arrhythmia and/or QTc-time >430 ms
  • History of severe kidney or liver disorder
  • Prostate or bladder disorder
  • Asthma or other obstructive respiratory disease
  • Current medication known to interact with levodopa, benserazide, or galantamine
  • Allergy to lactose, levodopa, benserazide, or galantamine

研究者

发起方
Translational Neuromodeling Unit, Institut für Biomedizinische Technik, Universität Zürich und ETH Zürich

相似试验